Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 509470 | NSE Symbol : | ISIN : INE01TL01014 | Industry : Finance & Investments |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
29-Jan-2025	10-Feb-2025	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and nine months ended 31st December 2024. Please find attached Outcome of Board Meeting held on 10th February, 2025 (As Per BSE Announcement Dated on: 10/02/2025)
16-Jan-2025	16-Jan-2025	Change in Directors	Please find attached intimation w.r.t. Appointment of Additional Directors (Non-Executive Independent Director).
23-Oct-2024	05-Nov-2024	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2024 inter alia to consider and approve Unaudited financial results for the quarter and half year ended 30th September 2024. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we hereby inform you that a Meeting of the Board of Directors of the Company was held today i.e. 5th November 2024 which commenced at 12.30 p.m. and concluded at 02.30 p.m. Read less.. Please find enclosed intimation w.r.t. Appointment of Company Secretary and Compliance Officer (As Per BSE Announcement Dated on 05.11.2024)
19-Jul-2024	30-Jul-2024	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2024 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter ended 30th June 2024. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.07.2024 till 01.08.2024 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 02.08.2024. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 30th July, 2024 which commenced at 12.30 p.m. and concluded at 2.30 p.m. The meeting inter alia considered and approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2024 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Further to our letter No. Sy/BSE/88 dated 28th June, 2024, we wish to inform you that the Board in its meeting held today has also approved the resignation of Mrs. Sangeeta Rohit Naik, Company Secretary and Compliance Officer of the Company with effect from the closing hours of 27th September, 2024. (As Per BSE Announcement dated on 30.07.2024)
22-Apr-2024	30-Apr-2024	Accounts	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2024 and recommendation of Dividend if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.04.2024 till 02.05.2024 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 03.05.2024. Final Dividend & Audited Results (As per BSE Bulletin dated on 22/04/2024) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company was held today i.e. 30th April, 2024, which commenced at 12.30 p.m. and concluded at 3.30 p.m. The meeting inter alia transacted the following business: 1)Audited Financial Results; 2) Dividend; 3) Book Closure; 4) Annual General Meeting; 5(i) Appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors; 5(ii) Re-appointment of Mr. Vikas Mukesh Jain (DIN 09126269), as a Director of the Company liable to retire by rotation.; 5(iii) Appointment of Mr. Swanand Lele, C.A., as an Internal Auditor of the Company with effect from 10th July, 2024 on the existing terms and conditions of his employment. with the Company. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), we wish to inform you that the Board of Directors at its Meeting held on 30th April, 2024 has considered and approved the appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors of the Company, for the financial year ending 31st March, 2025 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), we wish to inform you that the Board of Directors at its Meeting held on 30th April, 2024 has approved the re-appointment of Mr. Vikas Mukesh Jain (DIN 09126269) as a Non-Executive Non-Independent Director of the Company, liable to retire by rotation, subject to the approval of the Members. (As Per BSE Announcement Dated on 30.04.2024)
29-Jan-2024	07-Feb-2024	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter and nine months ended 31st December 2023. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.01.2024 till 09.02.2024 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 10.02.2024. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 7th February, 2024 which commenced at 12.30 p.m. and concluded at 2.00 p.m. The meeting interalia considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2023 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. (As Per BSE Announcement dated on 07.02.2024)
31-Oct-2023	10-Nov-2023	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter and half year ended 30th September 2023. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.10.2023 till 12.11.2023 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 13.11.2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 10th November, 2023 which commenced at 12.30 p.m. and concluded at 2.00 p.m. The meeting interalia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2023 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2023 along with the Limited Review Report duly signed by the Statutory Auditors of the Company. The said results were taken on record by the Board at its meeting held on 10th November, 2023. (As Per BSE Announcement Dated on 10/11/2023)
02-Aug-2023	10-Aug-2023	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter ended 30th June 2023. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.07.2023 till 12.08.2023 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 13.08.2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 10th August, 2023 which commenced at 12.30 p.m. and concluded at 2.30 p.m. The meeting inter alia considered and approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2023 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith a copy of the Unaudited Financial Results for the quarter ended 30th June, 2023 along with Limited Review Report duly signed by the Statutory Auditors of the Company. The said results were taken on record by the Board at its meeting held on 10th August, 2023. (As Per BSE Announcement dated on 10.08.2023)
16-May-2023	23-May-2023	Accounts	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2023 and recommendation of Dividend if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.04.2023 till 25.05.2023 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 26.05.2023. We wish to inform you that the Board of Directors at its meeting held on 23rd May, 2023 has recommended for consideration of the members at the Annual General Meeting to be held on 4th July, 2023 for payment of dividend of Rs. 15/- (previous year Rs.20/-) per Equity Share. The dividend, if sanctioned, at the Annual General Meeting will be made payable to those members whose name stand in the register of members of the Company on 27th June, 2023. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company was held today i.e 23rd May, 2023, which commenced at 12.30 p.m. and concluded at 3.30 p.m. The meeting inter alia transacted the following business: 1)Audited Financial Results; 2) Dividend; 3) Book Closure; 4) Annual General Meeting; 5(i) Appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors; 5(ii) Re-appointment of Mr. Shyam M. Ruia (DIN 00094600), as a Director of the Company liable to retire by rotation.; 5(iii) Re-appointment of Ms. Hema Renganathan (DIN 08684881), as a Whole Time Director of the Company for a period of 2 (two) years with effect from 1st July, 2023 to 30th June, 2025, on the existing terms and conditions of her employment.; 5(iv) Extension of the services of Mr. Shiraz M. Tejani, Internal Auditor of the Company. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors at its Meeting held on 23rd May, 2023 has considered and approved the appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors of the Company, for the financial year ending 31st March, 2024. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors at its Meeting held on 23rd May, 2023 has approved the re-appointment of Mr. Shyam M. Ruia (DIN 00094600) as a Non-Executive Non-Independent Director of the Company, liable to retire by rotation, subject to the approval of the Members. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors at its Meeting held on 23rd May, 2023 has approved the re-appointment of Ms. Hema Renganathan (DIN 08684881), as a Whole-Time Director of the Company, for a period of 2 (two) years, with effect from 1st July, 2023 to 30th June, 2025, on the existing terms and conditions of her employment, subject to the approval of the Members. (As Per BSE Announcement Dated on 23.05.2023)
02-Feb-2023	13-Feb-2023	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve the Un-Audited Financial Results (Provisional) of the Company for the quarter and nine months ended 31st December 2022. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.01.2023 till 15.02.2023 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 16.02.2023 Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 13th February, 2023 which commenced at 12.30 p.m. and concluded at 2.30 p.m. The meeting interalia considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2022 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2022 along with the Limited Review Report duly signed by the Statutory Auditors of the Company. The said results were taken on record by the Board at its meeting held on 13th February, 2023. (As Per BSE Announcement Dated on 13/02/2023)
03-Nov-2022	11-Nov-2022	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter and half year ended 30th September 2022. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.10.2022 till 13.11.2022 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 14.11.2022. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 11th November, 2022 which commenced at 12.30 p.m. and concluded at 2.30 p.m. The meeting interalia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2022 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2022 along with the Limited Review Report duly signed by the Statutory Auditors of the Company. The said results were taken on record by the Board at its meeting held on 11th November, 2022. (As Per BSE Announcement dated on 11.11.2022)
03-Aug-2022	11-Aug-2022	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter ended 30th June 2022. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.07.2022 till 13.08.2022 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 14.08.2022. We request to take the above information on record. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 11th August, 2022 which commenced at 12.30 p.m. and concluded at 2.00 p.m. The meeting inter alia considered and approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2022 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. Kindly take the same on your records. (As Per BSE Announcement Dated 11.08.2022)
16-May-2022	23-May-2022	Accounts	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2022 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2022 and recommendation of Dividend if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.04.2022 till 25.05.2022 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 26.05.2022. We request to take the above information on record. We wish to inform you that the Board of Directors at its meeting held on 23rd May, 2022 has recommended for consideration of the members at the Annual General Meeting to be held on 2nd August, 2022 for payment of dividend of Rs.20/- (previous year Rs.20/-) per Equity Share. The dividend, if sanctioned, at the Annual General Meeting will be made payable to those members whose name stand in the register of members of the Company on 26th July, 2022. You are requested to make a note of the same. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company was held today i.e 23rd May, 2022, which commenced at 12.30 p.m. and concluded at 3.30 p.m. The meeting inter alia transacted the following business: 1)Audited Financial Results; 2) Dividend; 3) Book Closure; 4) Annual General Meeting; 5(i) Appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors; 5(ii) Appointment of M/s. A M S & Co., Chartered Accountants as the Statutory Auditors of the Company; 5(iii) Re-appointment of Mr. Vikas Mukesh Jain (DIN 09126269), as a Director of the Company liable to retire by rotation.; (iv) Extension of the services of Mr. Shiraz M. Tejani, Internal Auditor of the Company. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors at its Meeting held on 23rd May, 2022 has considered and approved the appointment of SCP & Co., Practicing Company Secretaries as the Secretarial Auditors of the Company, for the financial year ending 31st March, 2023. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors at its Meeting held on 23rd May, 2022 has approved the re-appointment of Mr. Vikas Mukesh Jain (DIN 09126269) as a Non-Executive Non-Independent Director of the Company, liable to retire by rotation, subject to the approval of the Members. (As Per BSE Announcement Dated on 23.05.2022)
22-Mar-2022	22-Mar-2022	Change in Other Executives	Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 22nd March, 2022, which commenced at 12.30 p.m. and concluded at 2.00 p.m. The meeting inter alia transacted the following business: 1. Approved the appointment of Mrs. Sheela H. Pillai as the Chief Financial Officer of the Company with immediate effect, pursuant to the provisions of Section 203 and all other applicable provisions, if any, of the Companies Act, 2013, and rules made there under. 2. Approved the appointment Mrs. Sheela H. Pillai as the Principal Officer of the Company under the Prevention of Money Laundering Act, 2002 with immediate effect. Kindly take the same on your records.
01-Feb-2022	07-Feb-2022	Quarterly Results	Bombay Oxygen Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2022 inter alia to consider and approve the Un-audited Financial Results (Provisional) of the Company for the quarter and nine months ended 31st December 2021. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window in respect of dealing in the Equity Shares of the Company has been closed for all the Designated/ Connected Persons of the Company with effect from 01.01.2022 till 09.02.2022 (both days inclusive). The Trading window in respect of dealing in the Shares of the Company shall reopen from 10.02.2022. We request to take the above information on record. Pursuant to Regulation 30 & 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Bombay Oxygen Investments Limited was held today i.e. 7th February, 2022, which commenced at 12.30 p.m. and concluded at 2.00 p.m. The meeting inter alia transacted the following business: 1. Considered and approved the Unaudited Financial Results of the Company along with the Limited Review Report for the quarter and nine months ended 31st December, 2021. 2. Approved the extension of services of Mr. Bhupesh P. Mehta, Chief Financial Officer for a period of two years from 19th February, 2022 to 18th February, 2024, on the existing terms and conditions. Kindly take the same on your records. (As Per BSE Announcement dated on 07.02.2022)

1 2

LOGIN HERE

Bombay Oxygen Investments Ltd

Board Meeting